共 125 条
[11]
Turner MJ(2008)Role of the serotonin 3 receptor in stress-induced defecation Digestion 77 225-235
[12]
van Tilburg MA(2008)Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents Scand J Gastroenterol 43 1202-1211
[13]
Gangarosa LM(2016)A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome Gastroenterology 150 358-366
[14]
Dunlop SP(2016)A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome J Gastroenterol 9 874-882
[15]
Coleman NS(1997)Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women Aliment Pharmacol Ther 11 396-402
[16]
Blackshaw E(2006)Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study J Gastroenterol 40 491-494
[17]
Perkins AC(2000)The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress Gastroenterology 119 654-660
[18]
Singh G(2001)Validation of the Japanese version of the Rome II modulator questionnaire and irritable bowel syndrome severity index Am J Gastroenterol 96 3341-3347
[19]
Marsden CA(2006)The impact of irritable bowel syndrome on health-related quality of life Am J Gastroenterol 101 1057-1065
[20]
Miyata K(2010)Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome Gastroenterology 139 1877-1886